Management of melanoma during pregnancy

Dermatol Nurs. 2007 Apr;19(2):145-52, 161.

Abstract

There is no conclusive evidence that pregnancy adversely affects overall survival in patients with melanoma. Clinicians caring for pregnant patients should be as suspicious of changes in melanocytic nevi in these patients as they are for nonpregnant patients. Treatment of early-stage melanoma is the same irrespective of whether or not the patient is pregnant. Chemotherapeutic regimens for metastatic disease administered during pregnancy have not demonstrated significant efficacy.

Publication types

  • Review

MeSH terms

  • Adult
  • Age Distribution
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Causality
  • Female
  • Humans
  • Incidence
  • Maternal Age
  • Melanoma* / diagnosis
  • Melanoma* / epidemiology
  • Melanoma* / therapy
  • Middle Aged
  • Neoplasm Staging / methods
  • Postnatal Care
  • Pregnancy
  • Pregnancy Complications, Neoplastic* / diagnosis
  • Pregnancy Complications, Neoplastic* / epidemiology
  • Pregnancy Complications, Neoplastic* / therapy
  • Pregnancy Outcome
  • Prenatal Care
  • Prognosis
  • Prospective Studies
  • Retrospective Studies
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / epidemiology
  • Skin Neoplasms* / therapy
  • Survival Rate
  • United States / epidemiology